Targeting mPGES-1 as a treatment for inflammation which...

Details Targeting mPGES-1 as a treatment for inflammation which... Targeting mPGES-1 as a treatment for inflammation which...

2005-12-07

2009-10-27

Carlson, Karen Cochrane (Department: 1652)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving oxidoreductase

C435S007100, C435S233000

Reexamination Certificate

active

07608416

ABSTRACT:
The present invention relates to methods for the treatment of inflammation and pain without increasing cardiovascular risk by administration of an inhibitor of mPGES-1. The invention further is related to identifying inhibitors of mPGES-1 that do not increase cardiovascular risk when administered to an individual.

REFERENCES:
patent: 2003/0106085 (2003-06-01), Audoly et al.
patent: 2003/0171287 (2003-09-01), Morishita et al.
patent: 2004/0152148 (2004-08-01), Lambalot
Henriksson et al., “In vivo production of prostacycline and thromboxane in patients with acute myocardial infarction,” Br Heart J 55:543-548, 1985.
Wübert et al., “Simultaneous solid phase extraction, derivitization, and gas chromatographic mass spectrometric quantification of thromboxane and prostacyclin metabolites, prostaglandins, and isoprostanes in urine,” Anal Chem 69:2143-2146, 1987.
FitzGerald et al., 2001, N. Engl. J. Med. 345: 433-442.
Dannhardt et al., 2001, Eur. J. Med. Chem. 36: 109-126.
Bombardier et al., 2000, N. Engl. J. Med. 343: 1520-8, 2 p following 8.
McAdam et al., 1999, Proc. Natl. Acad. Sci. USA 96: 272-7.
Catella-Lawson et al., 1999, J. Pharmacol. Exp. Ther. 289: 735-41.
Cheng et al., 2002, Science 296: 539-541.
Morishita et al., 1990, J. Clin. Invest. 86: 1885-91.
Dowd et al., 2001, J. Clin. Invest. 108: 585-90.
Thomas et al., 1998, J. Clin. Invest. 102: 1994-2001.
Qi et al., 2002, J. Clin. Invest. 110: 61-9.
Francois et al., 2004, Hypertension 43: 364-9.
Kobayashi et al., 2004, J. Clin. Invest. 114: 784-94.
Cayatte et al., 2000, Arterioscler. Thromb. Vasc. Biol. 20: 1724-8.
Huo et al., 2003, Nat. Med. 9: 61-7.
FitzGerald, 2004, N. Engl. J. Med. 351: 1709-11.
Jakobsson et al., 1999, Proc. Natl. Acad. Sci. USA 96: 7220-7225.
Pini et al., 2005, Arterioscler. Thromb. Vasc. Biol. 25: 315-20.
Schneider et al., 2004, Kidney International. 65: 1205-13.
Trebino et al., 2003, PNAS 100: 9044-9049.
Fahmi et al., 2004, Curr. Opin. Rheumatology 16: 623-627.
Kojima et al., 2005, Fundam. Clin. Pharmacol. 19: 255-261.
Fabre et al., 2001, J. Clin. Invet. 107: 603-610.
Pratico et al., 1995, J. Biol. Chem. 270: 9800-9808.
Pratico et al., 1998, Proc. Natl. Acad. Sci. USA 95: 3449-3454.
Lawson et al., 1999, J. Biol. Chem., 274(35): 24441-24444.
Masse et al., 2005, J. Biomol. Screen. 10: 599-605.
Percival, 2003, Anal. Biochem. 313: 307-310.
Paramo et al., 2005, Current Drug Targets—Cardiovascular & Hematological Disorders 5(4): 303-311(9).
Kamei et al., 2004, J. Biol. Chem. 279(32): 33684-95.
Thoren et al., 2000, Eur. J. Biochem. 267: 6428-6434.
Thoren et al., 2003, J. Biol. Chem. 278:22199-22209.
Ciabattoni et al., 1979, J. Endocrinol. Invest. 2:173-182.

Affiliated with

Also associated with

Rating

Targeting mPGES-1 as a treatment for inflammation which... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeting mPGES-1 as a treatment for inflammation which..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting mPGES-1 as a treatment for inflammation which... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081276